LPS can activate toll-like receptor (TLR) 4, produce proinflammatory cytokines (tumor necrosis factor-α [TNF-α], interleukin [IL]-6 and IL-1), and contribute to injury and inflammation-driven tumor promotion [20]. This evidence concerns the gene TNF and neoplasm.